Health Dictionary Find a Doctor

Chronic myelogenous leukemia diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Badria Munir M.B.B.S.[2] , Shyam Patel [3]

Overview

The diagnosis of chronic myelogenous leukemia is confirmed via peripheral blood karyotyping or FISH showing presence of the translocation between chromosomes 9 and 22 (which causes the BCR gene to come into proximity with the ABL gene. A bone marrow biopsy can also be done to aid in the diagnosis and to better assess for Philadelphia chromosome-positive metaphases.

Diagnostic Study of Choice

Study of choice

The diagnosis of chronic myelogenous leukemia is confirmed via one or more of the following studies done on peripheral blood:

Peripheral blood smear

Peripheral blood smear may show:[2]

The various investigations should be performed in the following order:[2]

References

  1. 1.0 1.1 1.2 Le Gouill S, Talmant P, Milpied N, Daviet A, Ancelot M, Moreau P, Harousseau JL, Bataille R, Avet-Loiseau H (April 2000). “Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia”. J. Clin. Oncol. 18 (7): 1533–8. doi:10.1200/JCO.2000.18.7.1533. PMID 10735902.
  2. 2.0 2.1 Melo JV, Myint H, Galton DA, Goldman JM (January 1994). “P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?”. Leukemia. 8 (1): 208–11. PMID 8289491.

Template:WH Template:WS

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH